abs122.txt	background	&	aims		endoscopic	screening	for	colorectal	cancer	(crc)	is	performedat	longer	time	intervals	than	the	fecal	occult	blood	test	or	screens	breastor	prostate	this	causes	concerns	about	interval	cancers	which	have	beenproposed	to	progress	more	rapidly	we	compared	outcomes	of	patients	with	intervalcrcs	after	sigmoidoscopy	vs	crc	who	had	notbeen	screened	methods	performed	a	secondary	analysis	randomized	sigmoidoscopyscreening	trial	in	norway	98	684	participants	(age	50-64	years)	wererandomly	assigned	groups	that	were	(n=20	552)	not	(n=78	126)	invitedfor	from	1999	through	2001	followedfor	median	14	8	years	mortality	and	all-cause	mortalitybetween	individuals	underwent	diagnosed	30	daysor	(interval	group	n=163)	diagnosedwith	non-screened	(controls	n=1740)	all	crcs	controlgroup	identified	when	they	developed	symptoms	(clinically	detected	crcs)	analyses	stratified	by	site	used	cox	regression	estimatehazard	ratio	(hrs)	adjusted	age	sex	results	over	follow-up	period	43	groupdied	among	controls	525	died	mortality(adjusted	hr	0	95%	ci	72-1	35	p=	92)	rectosigmoid	1	10	63-1	92	74)	(adjustedhr	99	76-1	27	91)	did	differ	significantly	between	theinterval	clinicaltrials	gov	identifier	nct00119912conclusion	notdiffer	unscreenedpatients	clinically
